Login
$ADPT
$27.87 +$0.00 (0.0%) After hours

Insider Transactions

What Adaptive Biotechnologies Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 69 184
Total trades 112 343

Shares traded

3 months 12 months
Acquired 805,805 5,410,790
Disposed 962,983 7,247,335
Net activity −157,178 −1,836,545

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Rubinstein Julie President and COO Nov 13 Disclosed 10b5-1 sale · S −11,466 $28.93 −$332K 377,802
Rubinstein Julie President and COO Nov 13 Exercise / conversion · M +11,466 $12.14 +$139K 389,268
Rubinstein Julie President and COO Nov 12 Disclosed 10b5-1 sale · S −11,881 $29.40 −$349K 377,802
Rubinstein Julie President and COO Nov 12 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Nov 11 Disclosed 10b5-1 sale · S −6,898 $31.22 −$215K 377,802
Rubinstein Julie President and COO Nov 11 Disclosed 10b5-1 sale · S −4,983 $30.29 −$151K 384,700
Rubinstein Julie President and COO Nov 11 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Bobulsky Susan Chief Commercial Officer, MRD Nov 11 Disclosed 10b5-1 sale · S −1,875 $32.00 −$60K 387,475
Rubinstein Julie President and COO Nov 10 Disclosed 10b5-1 sale · S −1,900 $30.41 −$57.8K 377,802
Rubinstein Julie President and COO Nov 10 Disclosed 10b5-1 sale · S −9,981 $29.35 −$293K 379,702
Rubinstein Julie President and COO Nov 10 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Robins Chad M CEO and Chairman Nov 09 Gift · G −100,000 — — 2,080,518
Rubinstein Julie President and COO Nov 09 Disclosed 10b5-1 sale · S −2,400 $30.58 −$73.4K 377,802
Rubinstein Julie President and COO Nov 09 Disclosed 10b5-1 sale · S −8,381 $30.15 −$253K 380,202
Rubinstein Julie President and COO Nov 09 Disclosed 10b5-1 sale · S −1,100 $28.87 −$31.8K 388,583
Rubinstein Julie President and COO Nov 09 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Nov 06 Disclosed 10b5-1 sale · S −3,481 $27.88 −$97.1K 377,802
Rubinstein Julie President and COO Nov 06 Disclosed 10b5-1 sale · S −8,400 $27.32 −$229K 381,283
Rubinstein Julie President and COO Nov 06 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Nov 05 Disclosed 10b5-1 sale · S −500 $27.70 −$13.9K 377,802

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support